Short answer · Medically reviewed summary · Last updated: 2023-07-13
Hyperprolinemia Type II is an extremely rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by mutations in the PYCR2 gene, which is involved in the production of proline.
What is the prevalence of Hyperprolinemia Type II?
Prevalence of Hyperprolinemia Type II: how many people are affected worldwide, differences by sex and region, with sources.
Hyperprolinemia Type II is an extremely rare genetic disorder characterized by elevated levels of proline, an amino acid, in the blood and urine. This condition is caused by mutations in the PYCR2 gene, which is involved in the production of proline. Due to its rarity, there is limited information available regarding the prevalence of Hyperprolinemia Type II.
Although exact figures are not known, it is estimated that Hyperprolinemia Type II affects a very small number of individuals worldwide. The scarcity of reported cases suggests that this disorder is extremely uncommon. The condition is typically identified in infancy or early childhood, and symptoms may vary among affected individuals.
Given the rarity of Hyperprolinemia Type II, it is crucial for affected individuals and their families to consult with healthcare professionals who specialize in genetic disorders. Genetic testing and counseling can provide valuable insights and support for managing this condition.
